Morning Overview on MSN
Review finds GLP-1 weight-loss drugs may cut Alzheimer’s amyloid and tau
Drugs best known for helping people lose weight may also chip away at the proteins that define Alzheimer’s disease. A ...
DUBLIN--(BUSINESS WIRE)--The "Systemic Mastocytosis Pipeline Research Monitor, 2020 - Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook" report has been added to ...
The retrospective study of patient hospital data showed that current approaches to identifying a culprit drug often overidentify drugs unlikely to be responsible for Stevens-Johnson syndrome/toxic ...
Morning Overview on MSN
The Conversation: Review finds Alzheimer’s drugs show limited benefit
A new class of Alzheimer’s drugs promised to be the first treatments that actually slow the disease rather than just manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results